MicroRNA-29a Counteracts Synovitis in Knee Osteoarthritis Pathogenesis by Targeting VEGF

Abstract Synovitis contributes to the development of osteoarthritis (OA) of the knee. MicroRNAs regulate joint microenvironment homeostasis and deterioration. This study was undertaken to characterize the actions of microRNA-29a (miR-29a) to synovial remodeling in OA joints. Synovial specimens isola...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jih-Yang Ko, Mel S. Lee, Wei-Shiung Lian, Wen-Tsan Weng, Yi-Chih Sun, Yu-Shan Chen, Feng-Sheng Wang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/fa91fc2b14564efc8f14940ec11fcee4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fa91fc2b14564efc8f14940ec11fcee4
record_format dspace
spelling oai:doaj.org-article:fa91fc2b14564efc8f14940ec11fcee42021-12-02T11:40:51ZMicroRNA-29a Counteracts Synovitis in Knee Osteoarthritis Pathogenesis by Targeting VEGF10.1038/s41598-017-03616-w2045-2322https://doaj.org/article/fa91fc2b14564efc8f14940ec11fcee42017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-03616-whttps://doaj.org/toc/2045-2322Abstract Synovitis contributes to the development of osteoarthritis (OA) of the knee. MicroRNAs regulate joint microenvironment homeostasis and deterioration. This study was undertaken to characterize the actions of microRNA-29a (miR-29a) to synovial remodeling in OA joints. Synovial specimens isolated from patients with end-stage OA knees showed abundant fibrotic matrix and vessel histopathology concomitant with weak miR-29a expression. In vitro, miR-29a knockdown caused synovial fibroblasts to exhibit high expressions of collagen III, TGF-β1, MMP9, MMP13, and ADAMTS5, whereas miR-29a overexpression diminished these joint-deleterious factors. In collagenase-mediated OA pathogenesis, miR-29a-overexpressing transgenic mice showed minor responses to hyperplasia, macrophage infiltration, fibrosis, hyperangiogenesis, and VEGF expression in synovial lesions. These effects mitigated articular cartilage loss and gait aberrance of injured joints. Intra-articular administration of miR-29a precursor lessened the collagenase aggravation of excessive synovial remodeling reactions and thereby sustained joint tissue integrity. miR-29a lowered VEGF production and angiogenic activities in synovial fibroblasts through targeting the 3′-UTR of VEGF. Taken together, miR-29a deficiency exacerbated synovitis pathogenesis in the end-stage OA knees. miR-29a signaling fends off excessive synovial angiogenesis and fibrosis, which delays joint destruction. This study sheds new light on the protective effects against synovial deterioration and the therapeutic advantage of miR-29a in OA knees.Jih-Yang KoMel S. LeeWei-Shiung LianWen-Tsan WengYi-Chih SunYu-Shan ChenFeng-Sheng WangNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-14 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jih-Yang Ko
Mel S. Lee
Wei-Shiung Lian
Wen-Tsan Weng
Yi-Chih Sun
Yu-Shan Chen
Feng-Sheng Wang
MicroRNA-29a Counteracts Synovitis in Knee Osteoarthritis Pathogenesis by Targeting VEGF
description Abstract Synovitis contributes to the development of osteoarthritis (OA) of the knee. MicroRNAs regulate joint microenvironment homeostasis and deterioration. This study was undertaken to characterize the actions of microRNA-29a (miR-29a) to synovial remodeling in OA joints. Synovial specimens isolated from patients with end-stage OA knees showed abundant fibrotic matrix and vessel histopathology concomitant with weak miR-29a expression. In vitro, miR-29a knockdown caused synovial fibroblasts to exhibit high expressions of collagen III, TGF-β1, MMP9, MMP13, and ADAMTS5, whereas miR-29a overexpression diminished these joint-deleterious factors. In collagenase-mediated OA pathogenesis, miR-29a-overexpressing transgenic mice showed minor responses to hyperplasia, macrophage infiltration, fibrosis, hyperangiogenesis, and VEGF expression in synovial lesions. These effects mitigated articular cartilage loss and gait aberrance of injured joints. Intra-articular administration of miR-29a precursor lessened the collagenase aggravation of excessive synovial remodeling reactions and thereby sustained joint tissue integrity. miR-29a lowered VEGF production and angiogenic activities in synovial fibroblasts through targeting the 3′-UTR of VEGF. Taken together, miR-29a deficiency exacerbated synovitis pathogenesis in the end-stage OA knees. miR-29a signaling fends off excessive synovial angiogenesis and fibrosis, which delays joint destruction. This study sheds new light on the protective effects against synovial deterioration and the therapeutic advantage of miR-29a in OA knees.
format article
author Jih-Yang Ko
Mel S. Lee
Wei-Shiung Lian
Wen-Tsan Weng
Yi-Chih Sun
Yu-Shan Chen
Feng-Sheng Wang
author_facet Jih-Yang Ko
Mel S. Lee
Wei-Shiung Lian
Wen-Tsan Weng
Yi-Chih Sun
Yu-Shan Chen
Feng-Sheng Wang
author_sort Jih-Yang Ko
title MicroRNA-29a Counteracts Synovitis in Knee Osteoarthritis Pathogenesis by Targeting VEGF
title_short MicroRNA-29a Counteracts Synovitis in Knee Osteoarthritis Pathogenesis by Targeting VEGF
title_full MicroRNA-29a Counteracts Synovitis in Knee Osteoarthritis Pathogenesis by Targeting VEGF
title_fullStr MicroRNA-29a Counteracts Synovitis in Knee Osteoarthritis Pathogenesis by Targeting VEGF
title_full_unstemmed MicroRNA-29a Counteracts Synovitis in Knee Osteoarthritis Pathogenesis by Targeting VEGF
title_sort microrna-29a counteracts synovitis in knee osteoarthritis pathogenesis by targeting vegf
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/fa91fc2b14564efc8f14940ec11fcee4
work_keys_str_mv AT jihyangko microrna29acounteractssynovitisinkneeosteoarthritispathogenesisbytargetingvegf
AT melslee microrna29acounteractssynovitisinkneeosteoarthritispathogenesisbytargetingvegf
AT weishiunglian microrna29acounteractssynovitisinkneeosteoarthritispathogenesisbytargetingvegf
AT wentsanweng microrna29acounteractssynovitisinkneeosteoarthritispathogenesisbytargetingvegf
AT yichihsun microrna29acounteractssynovitisinkneeosteoarthritispathogenesisbytargetingvegf
AT yushanchen microrna29acounteractssynovitisinkneeosteoarthritispathogenesisbytargetingvegf
AT fengshengwang microrna29acounteractssynovitisinkneeosteoarthritispathogenesisbytargetingvegf
_version_ 1718395558483197952